Qiagen NV (QGEN)
43.26
+0.62
(+1.45%)
USD |
NYSE |
May 31, 16:00
43.29
+0.03
(+0.07%)
Pre-Market: 20:00
Qiagen Accounts Payable (Quarterly): 75.33M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 75.33M |
December 31, 2023 | 84.16M |
September 30, 2023 | 76.89M |
June 30, 2023 | 83.94M |
March 31, 2023 | 84.39M |
December 31, 2022 | 98.73M |
September 30, 2022 | 82.84M |
June 30, 2022 | 85.20M |
March 31, 2022 | 87.01M |
December 31, 2021 | 101.22M |
September 30, 2021 | 94.26M |
June 30, 2021 | 103.00M |
March 31, 2021 | 103.47M |
December 31, 2020 | 118.15M |
September 30, 2020 | 90.86M |
June 30, 2020 | 94.85M |
March 31, 2020 | 71.14M |
December 31, 2019 | 84.77M |
September 30, 2019 | 64.82M |
June 30, 2019 | 56.53M |
March 31, 2019 | 63.24M |
December 31, 2018 | 69.42M |
September 30, 2018 | 59.91M |
June 30, 2018 | 60.94M |
March 31, 2018 | 46.50M |
Date | Value |
---|---|
December 31, 2017 | 59.20M |
September 30, 2017 | 50.55M |
June 30, 2017 | 48.50M |
March 31, 2017 | 44.58M |
December 31, 2016 | 51.22M |
September 30, 2016 | 40.87M |
June 30, 2016 | 45.56M |
March 31, 2016 | 38.93M |
December 31, 2015 | 52.31M |
September 30, 2015 | 41.94M |
June 30, 2015 | 42.21M |
March 31, 2015 | 45.07M |
December 31, 2014 | 46.12M |
September 30, 2014 | 42.06M |
June 30, 2014 | 44.18M |
March 31, 2014 | 40.93M |
December 31, 2013 | 50.87M |
September 30, 2013 | 40.10M |
June 30, 2013 | 43.47M |
March 31, 2013 | 40.76M |
December 31, 2012 | 51.31M |
September 30, 2012 | 56.09M |
June 30, 2012 | 60.69M |
March 31, 2012 | 42.10M |
December 31, 2011 | 59.85M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
56.53M
Minimum
Jun 2019
118.15M
Maximum
Dec 2020
87.08M
Average
84.98M
Median
Accounts Payable (Quarterly) Benchmarks
MoonLake Immunotherapeutics | 1.630M |
LENZ Therapeutics Inc | 7.131M |
Thermo Fisher Scientific Inc | 2.555B |
uniQure NV | 5.231M |
ProQR Therapeutics NV | 0.3574M |